Search results
FDA gives nod to RSV vaccine for people in their 50s
Medical Xpress· 53 minutes agoDrugmaker GSK's Arexvy vaccine, as well as vaccines from Pfizer and Moderna, are already approved for use in adults 60 and older, since age brings higher...
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 6 hours agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo Finance· 7 hours agoAbrysvo recorded sales of $890 million in 2023. In April this year, Pfizer announced that a phase...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 5 days agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 6 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
FDA vaccine advisors expected to vote on new COVID-19 booster formula
ABC Action News Tampa Bay· 6 days agoThe FDA’s vaccine advisory committee is expected to meet Tuesday. It was postponed due to the...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
Weik Capital Management Sells 10,839 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 1 day agoWeik Capital Management decreased its position in Pfizer Inc. (NYSE:PFE – Free Report) by 26.3% in the 4th quarter, according to the company in its most recent filing with ...
FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
NBC 10 - FOX 14 Monroe· 5 days agoWASHINGTON (AP) — Government advisers Wednesday said it’s time to update the recipe for the COVID-19...
FDA Advisers Recommend Omicron-Focused COVID Boosters for Fall
Homenewshere.com· 4 days agoFDA advisers recommended that the new COVID-19 boosters for fall target the Omicron variant, which...